Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.370
-0.030 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -40.94 | -56.2 | -25.33 | -14.49 | -5.46 | -0.99 | |
| Other Amortization | - | - | - | - | 0 | 0 | |
| Stock-Based Compensation | 3.24 | 4.63 | 9.15 | 4.7 | 1.86 | 0.01 | |
| Other Operating Activities | 10.76 | 11.84 | - | - | 0.03 | 0.08 | |
| Change in Accounts Payable | 2.17 | -2.67 | 3.27 | 0.35 | -0.7 | 0.97 | |
| Change in Other Net Operating Assets | 1.8 | 2.44 | -4.41 | 0.31 | 0.29 | -0.55 | |
| Operating Cash Flow | -22.97 | -39.97 | -17.31 | -9.13 | -3.97 | -0.48 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.53 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 0.53 | |
| Issuance of Common Stock | 29.26 | 17.34 | 0 | 46.74 | 12.04 | - | |
| Other Financing Activities | - | - | - | - | - | -0.09 | |
| Financing Cash Flow | 29.26 | 17.34 | 0 | 46.74 | 12.04 | 0.44 | |
| Net Cash Flow | 6.28 | -22.62 | -17.31 | 37.61 | 8.07 | -0.03 | |
| Free Cash Flow | -22.97 | -39.97 | -17.31 | -9.13 | -3.97 | -0.48 | |
| Free Cash Flow Per Share | -2.08 | -4.43 | -2.12 | -1.20 | -0.63 | -1.69 | |
| Levered Free Cash Flow | -11.8 | -23.75 | -7.93 | -3.73 | -3.02 | -0.3 | |
| Unlevered Free Cash Flow | -11.8 | -23.75 | -7.93 | -3.73 | -3.02 | -0.28 | |
| Change in Net Working Capital | -3.97 | 0.23 | 1.14 | -0.66 | 0.73 | -0.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.